CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Koji Shinoda, Yasunobu Yoshikai

    Research output: Contribution to journal › Comment/debate › peer-review

    Fingerprint

    Dive into the research topics of 'CD30 ligand could be a new therapeutic target for central nervous system autoimmunity'. Together they form a unique fingerprint.